Baby Formula Makers Eyed by Antitrust

Osem-Nestle with its Materna brand; Promedico, maker of Similac; Medici Medical, with its Optimal; and Teva Pharmaceuticals, with Nutrilon share a NIS 500 million market, but Materna and Similac control 97% of it.

Gabriella Davidovich-Weisberg
Send in e-mailSend in e-mail
Gabriella Davidovich-Weisberg

Comments